Dutch molecular imaging developer MILabs has delivered its Vector5 CT preclinical imaging scanner to the Istituto Oncologico Veneto in Padova, Italy.
The institute plans to use the PET/SPECT/CT system to support its translational oncology mission and advance its research for personalizing treatment of solid tumors, according to MILabs.
